NVOS - חובות ארוכי טווח של החברה Novo Integrated Sciences Corp

Novo Integrated Sciences generates revenue through comprehensive wellness, combining the sale of wellness products, physiotherapy, and digital solutions for preventive care. Operations are conducted exclusively within the US jurisdiction, which eliminates geopolitical risks. This chart of the market price on the GURU.Markets platform reflects the asset's dynamics, where long-term debt stands at 0.00. The business advantage lies in the synergy of diagnostics and AI to create personalized treatment programs.

Professional asset selection begins with an analysis of debt load to minimize credit risks. This metric aggregates obligations with a maturity of over one year, determining the stability of the capital structure. For Novo Integrated Sciences (NVOS), controlling borrowings is critical when scaling the medical services ecosystem and commercializing innovations. Historical lows in the business's long-term debt ratio confirm financial autonomy, while peak values on the chart signal an increased probability of default.